Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics
All laboratory tests have test performance characteristics (TPCs), whether or not they are explicitly known to the laboratorian or the pathologist. TPCs are thus also an integral characteristic of immunohistochemistry (IHC) tests and other in situ, cell-based molecular assays such as DNA or RNA in s...
Gespeichert in:
| Veröffentlicht in: | Applied immunohistochemistry & molecular morphology 2017-02, Vol.25 (2), p.79-85 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 85 |
|---|---|
| container_issue | 2 |
| container_start_page | 79 |
| container_title | Applied immunohistochemistry & molecular morphology |
| container_volume | 25 |
| creator | Torlakovic, Emina E Cheung, Carol C D'Arrigo, Corrado Dietel, Manfred Francis, Glenn D Gilks, C Blake Hall, Jacqueline A Hornick, Jason L Ibrahim, Merdol Marchetti, Antonio Miller, Keith van Krieken, J Han Nielsen, Soren Swanson, Paul E Vyberg, Mogens Zhou, Xiaoge Taylor, Clive R |
| description | All laboratory tests have test performance characteristics (TPCs), whether or not they are explicitly known to the laboratorian or the pathologist. TPCs are thus also an integral characteristic of immunohistochemistry (IHC) tests and other in situ, cell-based molecular assays such as DNA or RNA in situ hybridization or aptamer-based testing. Because of their descriptive, in situ, cell-based nature, IHC tests have a limited repertoire of appropriate TPCs. Although only a few TPCs are relevant to IHC, proper selection of informative TPCs is nonetheless essential for the development of and adherence to appropriate quality assurance measures in the IHC laboratory. This paper describes the TPCs that are relevant to IHC testing and emphasizes the role of TPCs in the validation of IHC tests. This is part 2 of the 4-part series "Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine." |
| doi_str_mv | 10.1097/PAI.0000000000000444 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1877815864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1867544393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-95b392f835f2785a005610360b8f2f685b0484c58b750102bc6b2b90c00b12a23</originalsourceid><addsrcrecordid>eNqNUVtLwzAUDqJ4_wciefSl8-TWpr6NMXUwccJ8LklMWaRtZtIK-zn-U1udIuKD5-UcON8NPoTOCIwI5NnlYjwbwc_hnO-gQyIYSzgIuTvcnCQUSHqAjmJ8BqCUcb6PDqgkkgqZHaK36auvutb5BvsSP3Sqcu0Gj2PsgmqMxaUPeFK5xhlV4Vldd41fudh6s7J1v8MGuwa3K4unQQ0Ki2CNi4PcnX1yxjUWJ3ihQovp1d_8pY0tXtjQO9UflpOVCsq0NvR_Z-IJ2itVFe3pdh-jx-vpcnKbzO9vZpPxPDFc0DbJhWY5LSUTJc2kUAAiJcBS0LKkZSqFBi65EVJnAghQbVJNdQ4GQBOqKDtGF5-66-Bfuj5U0Qc0tqpUY30XCyKzTBIhU_4PaJoJzlnOeij_hJrgYwy2LNbB1SpsCgLF0GPR91j87rGnnW8dOl3bp2_SV3HsHSlbmZs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1867544393</pqid></control><display><type>article</type><title>Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Torlakovic, Emina E ; Cheung, Carol C ; D'Arrigo, Corrado ; Dietel, Manfred ; Francis, Glenn D ; Gilks, C Blake ; Hall, Jacqueline A ; Hornick, Jason L ; Ibrahim, Merdol ; Marchetti, Antonio ; Miller, Keith ; van Krieken, J Han ; Nielsen, Soren ; Swanson, Paul E ; Vyberg, Mogens ; Zhou, Xiaoge ; Taylor, Clive R</creator><creatorcontrib>Torlakovic, Emina E ; Cheung, Carol C ; D'Arrigo, Corrado ; Dietel, Manfred ; Francis, Glenn D ; Gilks, C Blake ; Hall, Jacqueline A ; Hornick, Jason L ; Ibrahim, Merdol ; Marchetti, Antonio ; Miller, Keith ; van Krieken, J Han ; Nielsen, Soren ; Swanson, Paul E ; Vyberg, Mogens ; Zhou, Xiaoge ; Taylor, Clive R ; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path)</creatorcontrib><description>All laboratory tests have test performance characteristics (TPCs), whether or not they are explicitly known to the laboratorian or the pathologist. TPCs are thus also an integral characteristic of immunohistochemistry (IHC) tests and other in situ, cell-based molecular assays such as DNA or RNA in situ hybridization or aptamer-based testing. Because of their descriptive, in situ, cell-based nature, IHC tests have a limited repertoire of appropriate TPCs. Although only a few TPCs are relevant to IHC, proper selection of informative TPCs is nonetheless essential for the development of and adherence to appropriate quality assurance measures in the IHC laboratory. This paper describes the TPCs that are relevant to IHC testing and emphasizes the role of TPCs in the validation of IHC tests. This is part 2 of the 4-part series "Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine."</description><identifier>ISSN: 1541-2016</identifier><identifier>EISSN: 1533-4058</identifier><identifier>DOI: 10.1097/PAI.0000000000000444</identifier><identifier>PMID: 28182587</identifier><language>eng</language><publisher>United States</publisher><subject>Humans ; Immunohistochemistry - standards ; Precision Medicine ; Reproducibility of Results ; Sensitivity and Specificity</subject><ispartof>Applied immunohistochemistry & molecular morphology, 2017-02, Vol.25 (2), p.79-85</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-95b392f835f2785a005610360b8f2f685b0484c58b750102bc6b2b90c00b12a23</citedby><cites>FETCH-LOGICAL-c452t-95b392f835f2785a005610360b8f2f685b0484c58b750102bc6b2b90c00b12a23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28182587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Torlakovic, Emina E</creatorcontrib><creatorcontrib>Cheung, Carol C</creatorcontrib><creatorcontrib>D'Arrigo, Corrado</creatorcontrib><creatorcontrib>Dietel, Manfred</creatorcontrib><creatorcontrib>Francis, Glenn D</creatorcontrib><creatorcontrib>Gilks, C Blake</creatorcontrib><creatorcontrib>Hall, Jacqueline A</creatorcontrib><creatorcontrib>Hornick, Jason L</creatorcontrib><creatorcontrib>Ibrahim, Merdol</creatorcontrib><creatorcontrib>Marchetti, Antonio</creatorcontrib><creatorcontrib>Miller, Keith</creatorcontrib><creatorcontrib>van Krieken, J Han</creatorcontrib><creatorcontrib>Nielsen, Soren</creatorcontrib><creatorcontrib>Swanson, Paul E</creatorcontrib><creatorcontrib>Vyberg, Mogens</creatorcontrib><creatorcontrib>Zhou, Xiaoge</creatorcontrib><creatorcontrib>Taylor, Clive R</creatorcontrib><creatorcontrib>From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path)</creatorcontrib><title>Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics</title><title>Applied immunohistochemistry & molecular morphology</title><addtitle>Appl Immunohistochem Mol Morphol</addtitle><description>All laboratory tests have test performance characteristics (TPCs), whether or not they are explicitly known to the laboratorian or the pathologist. TPCs are thus also an integral characteristic of immunohistochemistry (IHC) tests and other in situ, cell-based molecular assays such as DNA or RNA in situ hybridization or aptamer-based testing. Because of their descriptive, in situ, cell-based nature, IHC tests have a limited repertoire of appropriate TPCs. Although only a few TPCs are relevant to IHC, proper selection of informative TPCs is nonetheless essential for the development of and adherence to appropriate quality assurance measures in the IHC laboratory. This paper describes the TPCs that are relevant to IHC testing and emphasizes the role of TPCs in the validation of IHC tests. This is part 2 of the 4-part series "Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine."</description><subject>Humans</subject><subject>Immunohistochemistry - standards</subject><subject>Precision Medicine</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><issn>1541-2016</issn><issn>1533-4058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUVtLwzAUDqJ4_wciefSl8-TWpr6NMXUwccJ8LklMWaRtZtIK-zn-U1udIuKD5-UcON8NPoTOCIwI5NnlYjwbwc_hnO-gQyIYSzgIuTvcnCQUSHqAjmJ8BqCUcb6PDqgkkgqZHaK36auvutb5BvsSP3Sqcu0Gj2PsgmqMxaUPeFK5xhlV4Vldd41fudh6s7J1v8MGuwa3K4unQQ0Ki2CNi4PcnX1yxjUWJ3ihQovp1d_8pY0tXtjQO9UflpOVCsq0NvR_Z-IJ2itVFe3pdh-jx-vpcnKbzO9vZpPxPDFc0DbJhWY5LSUTJc2kUAAiJcBS0LKkZSqFBi65EVJnAghQbVJNdQ4GQBOqKDtGF5-66-Bfuj5U0Qc0tqpUY30XCyKzTBIhU_4PaJoJzlnOeij_hJrgYwy2LNbB1SpsCgLF0GPR91j87rGnnW8dOl3bp2_SV3HsHSlbmZs</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Torlakovic, Emina E</creator><creator>Cheung, Carol C</creator><creator>D'Arrigo, Corrado</creator><creator>Dietel, Manfred</creator><creator>Francis, Glenn D</creator><creator>Gilks, C Blake</creator><creator>Hall, Jacqueline A</creator><creator>Hornick, Jason L</creator><creator>Ibrahim, Merdol</creator><creator>Marchetti, Antonio</creator><creator>Miller, Keith</creator><creator>van Krieken, J Han</creator><creator>Nielsen, Soren</creator><creator>Swanson, Paul E</creator><creator>Vyberg, Mogens</creator><creator>Zhou, Xiaoge</creator><creator>Taylor, Clive R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20170201</creationdate><title>Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics</title><author>Torlakovic, Emina E ; Cheung, Carol C ; D'Arrigo, Corrado ; Dietel, Manfred ; Francis, Glenn D ; Gilks, C Blake ; Hall, Jacqueline A ; Hornick, Jason L ; Ibrahim, Merdol ; Marchetti, Antonio ; Miller, Keith ; van Krieken, J Han ; Nielsen, Soren ; Swanson, Paul E ; Vyberg, Mogens ; Zhou, Xiaoge ; Taylor, Clive R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-95b392f835f2785a005610360b8f2f685b0484c58b750102bc6b2b90c00b12a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Humans</topic><topic>Immunohistochemistry - standards</topic><topic>Precision Medicine</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Torlakovic, Emina E</creatorcontrib><creatorcontrib>Cheung, Carol C</creatorcontrib><creatorcontrib>D'Arrigo, Corrado</creatorcontrib><creatorcontrib>Dietel, Manfred</creatorcontrib><creatorcontrib>Francis, Glenn D</creatorcontrib><creatorcontrib>Gilks, C Blake</creatorcontrib><creatorcontrib>Hall, Jacqueline A</creatorcontrib><creatorcontrib>Hornick, Jason L</creatorcontrib><creatorcontrib>Ibrahim, Merdol</creatorcontrib><creatorcontrib>Marchetti, Antonio</creatorcontrib><creatorcontrib>Miller, Keith</creatorcontrib><creatorcontrib>van Krieken, J Han</creatorcontrib><creatorcontrib>Nielsen, Soren</creatorcontrib><creatorcontrib>Swanson, Paul E</creatorcontrib><creatorcontrib>Vyberg, Mogens</creatorcontrib><creatorcontrib>Zhou, Xiaoge</creatorcontrib><creatorcontrib>Taylor, Clive R</creatorcontrib><creatorcontrib>From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Applied immunohistochemistry & molecular morphology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Torlakovic, Emina E</au><au>Cheung, Carol C</au><au>D'Arrigo, Corrado</au><au>Dietel, Manfred</au><au>Francis, Glenn D</au><au>Gilks, C Blake</au><au>Hall, Jacqueline A</au><au>Hornick, Jason L</au><au>Ibrahim, Merdol</au><au>Marchetti, Antonio</au><au>Miller, Keith</au><au>van Krieken, J Han</au><au>Nielsen, Soren</au><au>Swanson, Paul E</au><au>Vyberg, Mogens</au><au>Zhou, Xiaoge</au><au>Taylor, Clive R</au><aucorp>From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics</atitle><jtitle>Applied immunohistochemistry & molecular morphology</jtitle><addtitle>Appl Immunohistochem Mol Morphol</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>25</volume><issue>2</issue><spage>79</spage><epage>85</epage><pages>79-85</pages><issn>1541-2016</issn><eissn>1533-4058</eissn><abstract>All laboratory tests have test performance characteristics (TPCs), whether or not they are explicitly known to the laboratorian or the pathologist. TPCs are thus also an integral characteristic of immunohistochemistry (IHC) tests and other in situ, cell-based molecular assays such as DNA or RNA in situ hybridization or aptamer-based testing. Because of their descriptive, in situ, cell-based nature, IHC tests have a limited repertoire of appropriate TPCs. Although only a few TPCs are relevant to IHC, proper selection of informative TPCs is nonetheless essential for the development of and adherence to appropriate quality assurance measures in the IHC laboratory. This paper describes the TPCs that are relevant to IHC testing and emphasizes the role of TPCs in the validation of IHC tests. This is part 2 of the 4-part series "Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine."</abstract><cop>United States</cop><pmid>28182587</pmid><doi>10.1097/PAI.0000000000000444</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1541-2016 |
| ispartof | Applied immunohistochemistry & molecular morphology, 2017-02, Vol.25 (2), p.79-85 |
| issn | 1541-2016 1533-4058 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1877815864 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Humans Immunohistochemistry - standards Precision Medicine Reproducibility of Results Sensitivity and Specificity |
| title | Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T15%3A01%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20Quality%20Assurance%20for%20Clinical%20Immunohistochemistry%20in%20the%20Era%20of%20Precision%20Medicine%20-%20Part%202:%20Immunohistochemistry%20Test%20Performance%20Characteristics&rft.jtitle=Applied%20immunohistochemistry%20&%20molecular%20morphology&rft.au=Torlakovic,%20Emina%20E&rft.aucorp=From%20the%20International%20Society%20for%20Immunohistochemistry%20and%20Molecular%20Morphology%20(ISIMM)%20and%20International%20Quality%20Network%20for%20Pathology%20(IQN%20Path)&rft.date=2017-02-01&rft.volume=25&rft.issue=2&rft.spage=79&rft.epage=85&rft.pages=79-85&rft.issn=1541-2016&rft.eissn=1533-4058&rft_id=info:doi/10.1097/PAI.0000000000000444&rft_dat=%3Cproquest_cross%3E1867544393%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1867544393&rft_id=info:pmid/28182587&rfr_iscdi=true |